
This study investigated lung infections caused by antibiotic-resistant strains of Pseudomonas aeruginosa in immunocompromised individuals, such as those with cystic fibrosis. The researchers demonstrated that extracellular vesicles (EVs) secreted by human airway epithelial cells (AEC) deliver specific RNA fragments to P. aeruginosa, targeting the fluoroquinolone efflux pump MexHI-OpmD. This process reduces the protein levels of MexH, MexI, and OpmD, leading to increased sensitivity of P. aeruginosa to ciprofloxacin, a fluoroquinolone antibiotic. The transfer of an 18S rRNA fragment also contributes to this increased sensitivity. The findings suggest that combining these RNA fragments with ciprofloxacin in nanoparticles or EVs may be beneficial for treating antibiotic-resistant P. aeruginosa infections.
Like
Save
Share